The case for a new national program for the development of cancer therapeutics.

Schmidt Lh, Freireich Ej, Skipper He, Gehan Ea, Rall Dp, Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer chemotherapy reports. ,vol. 50, pp. 219- 244 ,(1966)

Philip S. Schein, Preclinical Toxicology of Anticancer Agents Cancer Research. ,vol. 37, pp. 1934- 1937 ,(1977)

BARNETT ROSENBERG, LORETTA VAN CAMP, THOMAS KRIGAS, Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode Nature. ,vol. 205, pp. 698- 699 ,(1965) , 10.1038/205698A0

PETER B. SCHIFF, JANE FANT, SUSAN B. HORWITZ, Promotion of microtubule assembly in vitro by taxol Nature. ,vol. 277, pp. 665- 667 ,(1979) , 10.1038/277665A0

John M Goldman, Tyrosine-kinase inhibition in treatment of chronic myeloid leukaemia The Lancet. ,vol. 355, pp. 1031- 1032 ,(2000) , 10.1016/S0140-6736(00)02029-8

D Lebwohl, R Canetta, Clinical development of platinum complexes in cancer therapy: an historical perspective and an update European Journal of Cancer. ,vol. 34, pp. 1522- 1534 ,(1998) , 10.1016/S0959-8049(98)00224-X

S.S. Buttles, D.R. Newell, R.E.C. Henrar, T.A. Connors, Revisions of general guidelines for the preclinical toxicology of new cytotoxic anticancer agents in Europe European Journal of Cancer. ,vol. 31, pp. 408- 410 ,(1995) , 10.1016/0959-8049(94)00483-L

J. N. Weinstein, T. G. Myers, P. M. O'Connor, S. H. Friend, A. J. Fornace, K. W. Kohn, T. Fojo, S. E. Bates, L. V. Rubinstein, N. L. Anderson, J. K. Buolamwini, W. W. van Osdol, A. P. Monks, D. A. Scudiero, E. A. Sausville, D. W. Zaharevitz, B. Bunow, V. N. Viswanadhan, G. S. Johnson, R. E. Wittes, K. D. Paull, An Information-Intensive Approach to the Molecular Pharmacology of Cancer Science. ,vol. 275, pp. 343- 349 ,(1997) , 10.1126/SCIENCE.275.5298.343

S. G. Arbuck, A. J. Murgo, J. M. Pluda, E. A. Sausville, P. T. C. Ho, M. C. Christian, Promising new agents under development by the Division of Cancer Treatment, Diagnosis, and Centers of the National Cancer Institute. Seminars in Oncology. ,vol. 24, pp. 219- 240 ,(1997)

Scudiero Da, Paull Kd, Monks A, Sausville Ea, Johnson Gs, The NCI anti-cancer drug screen: a smart screen to identify effectors of novel targets. Anti-cancer Drug Design. ,vol. 12, pp. 533- 541 ,(1997)